🔴 Atea Pharmaceuticals is trading 10.71% down in pre-market with no clear company-specific catalyst identified

Atea Pharmaceuticals is trading 10.71% down at $4.92 after no clear company-specific catalyst was identified for August 25, 2026.

• The latest official investor-relations update remains the August 12 second-quarter financial release and business update; the latest SEC quarterly filing was submitted August 12.
• The broader market is higher pre-market, so the decline does not appear to be driven by broad risk-off sentiment.
• Volume information and a definitive overnight explanation were unavailable.